Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer

Clinical trial NCT03592407 · WITHDRAWN

Trial details

NCT number: NCT03592407
Sponsor: City of Hope Medical Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma Esophageal Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2018-07-01
Primary completion: 2020-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.